Ocular Drug Efficacy Studies and development process

Thanks to its unique and extensive experience in Ocular Drug Efficacy Studies, Iris Pharma supplies the necessary understanding and competences to guide your new pharmaceutical drugs through the drug development process.

Based on Dr Pierre-Paul Elena's 27 year expertise in Ocular Drug Efficacy Studies and on more than 45 highly experienced staff, Iris Pharma performs professional quality studies in preclinical ophthalmology research.

Our focus on the Ocular Drug Efficacy Studies creates value for our customers because it enables us to work quickly and accurately and to help our clients to market their drugs faster.

Ocular Drug Efficacy Studies with customized solutions

We not only perform highly controlled Ocular Drug Efficacy Studies to obtain regulatory authorization (registration studies), but also propose pilot studies (proof of concept) that correspond to simplified prospective Ocular Drug Efficacy Studies. These simplified studies offer the advantage of investigating the efficacy or penetration of a product following a very simplified study design, using a lower number of animals.

Highly controlled Ocular Drug Efficacy Studies

Our department of applied Ocular Drug Efficacy Studies can develop new animal models according to the specific requirements of our clients and also improves existing models. Today, we have experience in : Ocular Drug Efficacy Studies, retinopathy research, ocular pressure trial, ocular neovascularization etc.